BioCryst Pharmaceuticals Inc (BCRX)
8.43
+0.42
(+5.24%)
USD |
NASDAQ |
Nov 01, 16:00
8.50
+0.07
(+0.83%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap: 1.744B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.744B |
| October 31, 2024 | 1.657B |
| October 30, 2024 | 1.732B |
| October 29, 2024 | 1.680B |
| October 28, 2024 | 1.686B |
| October 25, 2024 | 1.645B |
| October 24, 2024 | 1.692B |
| October 23, 2024 | 1.668B |
| October 22, 2024 | 1.645B |
| October 21, 2024 | 1.556B |
| October 18, 2024 | 1.576B |
| October 17, 2024 | 1.550B |
| October 16, 2024 | 1.566B |
| October 15, 2024 | 1.548B |
| October 14, 2024 | 1.543B |
| October 11, 2024 | 1.537B |
| October 10, 2024 | 1.473B |
| October 09, 2024 | 1.500B |
| October 08, 2024 | 1.490B |
| October 07, 2024 | 1.539B |
| October 04, 2024 | 1.568B |
| October 03, 2024 | 1.535B |
| October 02, 2024 | 1.527B |
| October 01, 2024 | 1.527B |
| September 30, 2024 | 1.572B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.576B |
| September 26, 2024 | 1.568B |
| September 25, 2024 | 1.562B |
| September 24, 2024 | 1.579B |
| September 23, 2024 | 1.612B |
| September 20, 2024 | 1.678B |
| September 19, 2024 | 1.686B |
| September 18, 2024 | 1.647B |
| September 17, 2024 | 1.639B |
| September 16, 2024 | 1.636B |
| September 13, 2024 | 1.639B |
| September 12, 2024 | 1.603B |
| September 11, 2024 | 1.599B |
| September 10, 2024 | 1.597B |
| September 09, 2024 | 1.587B |
| September 06, 2024 | 1.651B |
| September 05, 2024 | 1.682B |
| September 04, 2024 | 1.713B |
| September 03, 2024 | 1.707B |
| August 30, 2024 | 1.798B |
| August 29, 2024 | 1.785B |
| August 28, 2024 | 1.769B |
| August 27, 2024 | 1.703B |
| August 26, 2024 | 1.703B |
| August 23, 2024 | 1.676B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
175.04M
Minimum
Nov 14 2019
3.649B
Maximum
Feb 16 2022
1.616B
Average
1.556B
Median
Market Cap Benchmarks
| Novavax Inc | 1.497B |
| AIM ImmunoTech Inc | 16.53M |
| Perspective Therapeutics Inc | 815.20M |
| Protalix BioTherapeutics Inc | 91.93M |
| Armata Pharmaceuticals Inc | 85.39M |
Market Cap Related Metrics
| PS Ratio | 4.431 |
| Price | 8.43 |
| Earnings Yield | -8.66% |